Core Viewpoint - UP Fintech Holding Limited (TIGR) is currently viewed as a more attractive investment option compared to Tradeweb Markets (TW) based on valuation metrics and earnings estimate revisions [3][7]. Valuation Metrics - TIGR has a forward P/E ratio of 14.40, significantly lower than TW's forward P/E of 40.80 [5]. - The PEG ratio for TIGR is 0.76, indicating better value relative to its expected earnings growth compared to TW's PEG ratio of 2.31 [5]. - TIGR's P/B ratio stands at 2.21, while TW's P/B ratio is higher at 5.01, suggesting that TIGR is undervalued compared to TW [6]. Analyst Outlook - TIGR holds a Zacks Rank of 2 (Buy), indicating a positive analyst outlook, while TW has a Zacks Rank of 3 (Hold) [3]. - The stronger estimate revision activity for TIGR suggests a more favorable earnings outlook compared to TW [7]. Value Grades - TIGR has been assigned a Value grade of B, reflecting its attractive valuation metrics, whereas TW has received a Value grade of F, indicating it is considered overvalued [6].

Core Viewpoint - The comparison between Fortrea Holdings Inc. (FTRE) and Illumina (ILMN) indicates that FTRE may offer better value for investors based on various financial metrics and analyst outlooks [1][3][7]. Valuation Metrics - FTRE has a forward P/E ratio of 12.99, significantly lower than ILMN's forward P/E of 21.31 [5]. - FTRE's PEG ratio stands at 0.37, while ILMN's PEG ratio is 1.77, suggesting FTRE is expected to grow at a more favorable rate relative to its price [5]. - FTRE's P/B ratio is 0.57, compared to ILMN's P/B of 6.03, indicating FTRE is trading at a lower valuation relative to its book value [6]. Analyst Outlook - FTRE currently holds a Zacks Rank of 2 (Buy), reflecting an improving earnings estimate revision activity, while ILMN has a Zacks Rank of 3 (Hold) [3][7]. - The improving earnings outlook for FTRE positions it as a more attractive option for value investors [7].

Funding and Investment - TerraPower announced a new funding round of $650 million to support the construction of its first commercial power plant [1] - Nvidia's venture arm, NVentures, participated in this funding round, marking its first investment in the energy sector [1] - Bill Gates and HD Hyundai, both existing investors, also contributed to this funding round [1] Project Development - TerraPower began construction of its first power plant in Wyoming in June 2024, although it has not yet received approval for the reactor [2] - The company anticipates receiving the necessary permits in the following year, supported by the favorable regulatory environment under the Trump administration [2] - The first reactor is expected to generate 345 megawatts of electricity, positioning it between conventional large reactors and future small modular reactors [2] Reactor Technology - TerraPower's Natrium reactors utilize molten sodium for cooling instead of water, allowing for a more efficient operation [3] - The design incorporates excess sodium to maintain operation during low demand periods, storing heat for later use when demand increases [3] - This operational flexibility enables Natrium reactors to maintain a steady output, addressing the challenge of nuclear plants' inability to easily ramp production up or down [3] Future Plans and Costs - The company claims it can complete a reactor within three years after the initial concrete is poured, although significant site preparation is required beforehand [7] - The projected cost for the first Natrium reactor could reach $4 billion, with the Department of Energy potentially covering half of this expense [7] - TerraPower previously considered a different reactor design but shifted to the Natrium design due to uncertainties [6]

Company Overview - Medtronic shares have increased by approximately 6% over the past month, outperforming the S&P 500 index [1] - The most recent earnings report is crucial for understanding the catalysts affecting the stock [1] Earnings Estimates - Estimates for Medtronic have trended downward, with a consensus estimate shift of -6.38% in the past month [2] - The overall direction of estimate revisions indicates a negative outlook for the stock [4] VGM Scores - Medtronic has a Growth Score of B, a Momentum Score of F, and a Value Score of C, resulting in an aggregate VGM Score of C [3] Market Outlook - The downward trend in estimates has led to a Zacks Rank of 4 (Sell) for Medtronic, suggesting expectations of below-average returns in the coming months [4] Industry Comparison - Medtronic is part of the Zacks Medical - Products industry, where Phibro Animal Health (PAHC) has gained 4.1% over the past month [5] - Phibro reported revenues of $347.8 million for the last quarter, reflecting a year-over-year increase of +32.1% [5] - Phibro's expected earnings for the current quarter are $0.52 per share, indicating a +26.8% change from the previous year, with a Zacks Rank of 1 (Strong Buy) [6]

Core Viewpoint - Target's stock has seen a slight increase of about 0.1% since the last earnings report, underperforming the S&P 500, raising questions about its future performance leading up to the next earnings release [1] Estimates Movement - Estimates for Target have trended downward over the past month, with the consensus estimate shifting down by 12.38% [2] VGM Scores - Target currently holds an average Growth Score of C, a Momentum Score of F, and a Value Score of A, placing it in the top 20% for the value investment strategy, resulting in an aggregate VGM Score of C [3] Outlook - The downward trend in estimates indicates a negative shift, with Target holding a Zacks Rank of 3 (Hold), suggesting an expectation of an in-line return from the stock in the coming months [4]

Company Overview - EnerSys shares have increased by approximately 2.8% since the last earnings report, outperforming the S&P 500 [1] - Recent estimates for EnerSys have trended downward, with a consensus estimate shift of -13.23% [2] Performance Metrics - EnerSys has a Growth Score of B and a Momentum Score of C, while it received an A grade for value, placing it in the top 20% for this investment strategy [3] - The overall VGM Score for EnerSys is A, indicating strong performance across multiple investment strategies [3] Outlook - The downward trend in estimates suggests a negative outlook for EnerSys, reflected in its Zacks Rank of 4 (Sell), indicating expectations of below-average returns in the coming months [4] Industry Comparison - EnerSys is part of the Zacks Manufacturing - Electronics industry, where Emerson Electric has seen a 9.6% increase in shares over the past month [5] - Emerson Electric reported revenues of $4.43 billion for the last quarter, with a year-over-year change of +1.3% and an EPS of $1.48, up from $1.36 a year ago [5] - For the current quarter, Emerson Electric is expected to post earnings of $1.51 per share, reflecting a +5.6% change from the previous year [6]

Company Overview - Wix.com shares have increased by approximately 2.3% over the past month, underperforming the S&P 500 index [1] - The most recent earnings report is essential to understand the key drivers affecting the stock [1] Earnings Estimates - Fresh estimates for Wix.com have trended downward, with the consensus estimate decreasing by 5.19% [2] VGM Scores - Wix.com has a strong Growth Score of A but a low Momentum Score of F, and a Value Score of D, placing it in the bottom 40% for value investment strategy [3] - The aggregate VGM Score for Wix.com is C, which is relevant for investors not focused on a single strategy [3] Outlook - The overall trend of estimates for Wix.com indicates a downward shift, with a Zacks Rank of 3 (Hold), suggesting an expectation of in-line returns in the coming months [4] Industry Comparison - Wix.com is part of the Zacks Computers - IT Services industry, where Dynatrace (DT) has seen a 2.7% increase in the past month [5] - Dynatrace reported revenues of $445.17 million for the last quarter, reflecting a year-over-year growth of 16.9% [5] - Dynatrace's expected earnings for the current quarter are $0.38 per share, indicating a year-over-year increase of 15.2%, with a Zacks Rank of 2 (Buy) [6]

Company Overview - Zoom Communications shares have decreased by approximately 5.6% over the past month, underperforming the S&P 500 [1] - The most recent earnings report is crucial for understanding the key drivers affecting the stock [1] Earnings Estimates - Fresh estimates for Zoom have trended upward in the past month, with a consensus estimate shift of 5.67% [2] VGM Scores - Zoom has a strong Growth Score of A, a Momentum Score of B, and a Value Score of C, resulting in an aggregate VGM Score of B [3] Outlook - The upward trend in estimates suggests a promising outlook for Zoom, leading to a Zacks Rank of 2 (Buy) [4] Industry Performance - Zoom is part of the Zacks Internet - Software industry, where Match Group has seen a 2.9% increase in the past month [5] - Match Group reported revenues of $831.18 million for the last quarter, reflecting a year-over-year decline of 3.3% [5] - Match Group's expected earnings for the current quarter are $0.79 per share, indicating a year-over-year increase of 64.6% [6]

Core Insights - The article emphasizes the importance of cash flow over mere profitability when evaluating a company's financial health and resilience [1][4][5] - It highlights specific stocks that are recommended for investment based on their cash flow performance and overall financial health [2][9] Cash Flow Importance - Cash is described as the lifeblood of any business, providing flexibility for decision-making, investment opportunities, and growth [3] - Positive cash flow indicates an increase in liquid assets, enabling companies to meet obligations, reinvest, and return wealth to shareholders, while negative cash flow suggests declining liquidity [5] Current Economic Context - The article notes that in light of global economic uncertainties and liquidity concerns, analyzing cash-generating efficiency is particularly relevant [4] Screening Parameters for Stocks - Stocks were screened for those with cash flow in the latest quarter at least equal to the 5-year average cash flow per share, indicating a positive trend [7] - Additional criteria included a Zacks Rank of 1 (Strong Buy), an average broker rating of 1, a current price of at least $5, and a VGM Score of B or better [8] Recommended Stocks - Sumitomo Corporation (SSUMY), IHI Corporation (IHICY), Nomad Foods Limited (NOMD), Great Lakes Dredge & Dock Corporation (GLDD), and Natural Gas Services Group, Inc. (NGS) are highlighted as stocks with rising cash flow above their five-year average [2][9] - Each of these companies has seen upward revisions in EPS estimates, reflecting improving outlooks and strong financial health [9] Company Profiles - **Sumitomo Corporation (SSUMY)**: Engaged in diverse business activities globally, with a 6% improvement in the Zacks Consensus Estimate for fiscal 2026 earnings per share [10][11] - **IHI Corporation (IHICY)**: Focuses on heavy machinery, with a 28.6% increase in the Zacks Consensus Estimate for fiscal 2026 earnings per share [11] - **Nomad Foods (NOMD)**: Specializes in frozen foods, with a 4% upward revision in current-year earnings estimate to $2.07 per share, indicating a 7.3% year-over-year increase [12] - **Great Lakes Dredge & Dock (GLDD)**: The largest provider of dredging services in the U.S., with a 39.1% upward revision in the 2025 earnings estimate to 96 cents per share [13] - **Natural Gas Services Group (NGS)**: Manufactures natural gas compressors, with an 18.6% improvement in the 2025 earnings estimate [14]

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) between May 9, 2024 and May 8, 2025, both dates inclusive (the “Class Period”), of the important July 14, 2025 lead plaintiff deadline. SO WHAT: If you purchased Iovance securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...